Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,108.40
(
-0.41%
)
US TECH 100
26,203.20
(
0.00%
)
Dow Jones
49,310.32
(
-0.36%
)
Brent Oil
100.82
(
-0.38%
)
Bitcoin
78,189.39
(
-0.11%
)
News Focus
News Focus
Post# of 517552
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Hoskuld

Send PM Follow Ignore
Followers 35
Posts 4006
Boards Moderated 0
Alias Born 08/07/2022

Hoskuld

Re: rx7171 post# 482621

Thursday, 02/06/2025 5:24:25 PM

Thursday, February 06, 2025 5:24:25 PM

Post# of 517552
Lilly and Biogen are losing money on those mAbs so far - not much incentive for a BP to pursue something that can't be a real blockbuster. US docs are reluctant to Rx and EU countries don't want to pay. That seems like plenty of incentive to stop development of marginal therapies.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News